Brinks Co: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Oct 31, 2014 and accepted by EDGAR at Oct 31, 2014, 18:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-07-01 to 2014-09-30 | $913.1m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-01-01 to 2014-09-30 | $2.81bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-07-01 to 2014-09-30 | $770.9m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2014-01-01 to 2014-09-30 | $2.32bn | us-gaap:CostOfRevenue |
| Operating income | 3 months2014-07-01 to 2014-09-30 | $47.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | −$14.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-07-01 to 2014-09-30 | $6.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2014-01-01 to 2014-09-30 | $18.3m | us-gaap:InterestExpense |
| Income tax | 3 months2014-07-01 to 2014-09-30 | $23.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-01-01 to 2014-09-30 | $36.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-07-01 to 2014-09-30 | $20.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | −$36.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | $0.41 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | −$0.75 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-07-01 to 2014-09-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-01-01 to 2014-09-30 | −$0.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 49,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 49,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | $72.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-01-01 to 2014-09-30 | $83.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2014-01-01 to 2014-09-30 | $14.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2014-09-30 | $223.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-30 | $978.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-30 | $2.27bn | us-gaap:Assets |
| Current liabilities | At period end2014-09-30 | $764.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-09-30 | $1.59bn | us-gaap:Liabilities |
| Long-term debt | At period end2014-09-30 | $400.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-09-30 | $33.8m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2014-09-30 | $59.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-09-30 | $632.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000078890-14-000030. Last ingested by Listed: Nov 4, 2026, 07:32 ET. Listed shows no prices and gives no investment advice.